MARKET

SENS

SENS

SENSEONICS
AMEX

Real-time Quotes | Nasdaq Last Sale

0.4646
+0.0032
+0.69%
After Hours: 0.4700 +0.0054 +1.16% 18:56 05/22 EDT
OPEN
0.4700
PREV CLOSE
0.4614
HIGH
0.4760
LOW
0.4535
VOLUME
2.01M
TURNOVER
--
52 WEEK HIGH
2.240
52 WEEK LOW
0.4500
MARKET CAP
95.03M
P/E (TTM)
-0.7551
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 9 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SENS stock price target is 1.042 with a high estimate of 2.000 and a low estimate of 0.2500.

EPS

SENS News

More
UBS Maintains Sell on Senseonics Holdings, Lowers Price Target to $0.25
UBS maintains Senseonics Holdings (AMEX:SENS) with a Sell and lowers the price target from $0.7 to $0.25.
Benzinga · 4d ago
Local Coverage Determination Proposed for Implantable Continuous Glucose Monitors by Medicare Administrative Contractors
Business Wire · 05/14 14:00
Senseonics Holdings (SENS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 05/07 16:30
Senseonics Announces Positive Coverage Decision for Eversense CGM from Several Blue Cross Blue Shield Plans
Business Wire · 05/06 21:05
Senseonics Eversense® Sensor Receives MRI Conditional Approval in Europe
Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced regulatory
Business Wire · 04/28 20:15
Senseonics announces new credit facilities with Highbridge Capital
seekingalpha · 04/22 21:53
Senseonics Enters into New Credit Facilities with Certain Funds Managed by Highbridge Capital Management, LLC
Business Wire · 04/22 13:11
Senseonics Announces Equity Grants To Employees Under Inducement Plan
Business Wire · 04/03 21:15

Industry

Biotechnology & Medical Research
+1.01%
Pharmaceuticals & Medical Research
+0.05%

Hot Stocks

Symbol
Price
%Change

About SENS

Senseonics Holdings, Inc. is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes. The Company's Eversense system consists of components, such as a sensor, which is inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user's mobile device, such as a smartphone, Apple Watch or tablet.
More

Webull offers kinds of Senseonics Holdings Inc stock information, including AMEX:SENS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SENS stock news, and many more online research tools to help you make informed decisions.